Next Article in Journal
Autoantibodies in SLE: Specificities, Isotypes and Receptors
Next Article in Special Issue
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
Previous Article in Journal / Special Issue
Bispecific CD3/HER2 Targeting FynomAb Induces Redirected T Cell-Mediated Cytolysis with High Potency and Enhanced Tumor Selectivity
 
 
Review

Article Versions Notes

Antibodies 2016, 5(1), 1; https://doi.org/10.3390/antib5010001
Action Date Notes Link
article xml uploaded. 26 December 2015 06:36 CET Original file https://www.mdpi.com/2073-4468/5/1/1/xml
article pdf uploaded. 26 December 2015 06:36 CET Version of Record https://www.mdpi.com/2073-4468/5/1/1/pdf
article html file updated 28 March 2016 11:29 CEST Original file -
article html file updated 26 March 2019 17:21 CET Update -
article html file updated 6 May 2019 03:49 CEST Update -
article html file updated 7 February 2020 02:46 CET Update https://www.mdpi.com/2073-4468/5/1/1/html
Back to TopTop